Trial Profile

Safety and Dose Finding Study of Different MOD-4023 Dose Levels Compared to Daily R-human Growth Hormone (hGH) Therapy in Pre-pubertal Growth Hormone Deficient Children

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 14 Apr 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Somatrogon (Primary)
Indications Somatotropin deficiency
Focus Therapeutic Use
Sponsors OPKO Health

Most Recent Events

06 Feb 2024 Status changed from active, no longer recruiting to completed.
18 Jun 2023 Results assessing long term efficacy and safety of somatrogon in pGHD presented at the 105th Annual Meeting of the Endocrine Society
18 Apr 2022 Planned End Date changed from 1 Dec 2021 to 1 Dec 2023.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com